A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
|Articles|December 7, 2021
Daily OTC Pearl: Zarbee’s for Children's Cough
Author(s)Saro Arakelians, PharmD
Advertisement
OTC/Lifestyle Pearl of the Day: Zarbee’s
Indication: Zarbee’s is indicated for children’s cough.
Insight:
- Zarbee’s contains vitamin C, vitamin D, and zinc.
- Dosing is suggested 3 ml for children 2 to 12 months of age and 4 ml for children 1 to 3 years of age.
- Zarbee’s is safe and effective for infants 2 months of age and older.
- Zarbee’s comes in different flavors, such as berry and grape.
- Directions: Shake well before using with a suggested 2 servings in 24 hours.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Post hoc STEP UP data at EASD 2026 show liver fat fell from 8.8% to 3.1% at 72 weeks in a 55-person MRI subgroup, though no placebo comparison was reported.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.
As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Intensive BP Control Cuts CV Risk Regardless of CKD Status
2
Phase 3 Trial Finds Adding Monoclonal Antibody to mRNA Vaccine Improves COVID-19 Immunization Tolerability
3
Semaglutide Normalized Liver Fat in Most Adults With Obesity
4
When Parents Decline the Vitamin K Shot: What Every Pharmacist Needs to Know
5